Moichor is an innovative veterinary diagnostics company that leverages artificial intelligence to provide rapid, accurate, and cost-effective diagnostic solutions for a wide range of animal species. Their flagship product, Pathview, is an AI-assisted hematology and cytology system designed for in-clinic use, delivering preliminary diagnostic results in as little as 15 minutes. Key Features and Functionality: - AI-Assisted Diagnostics: Pathview offers pathologist-level diagnostic results directly within veterinary clinics, utilizing advanced AI technology. - Rapid Result Delivery: Provides preliminary diagnostic results in as little as 15 minutes, enabling swift clinical decision-making. - Broad Species Support: Capable of performing complete blood counts (CBC) and cytology evaluations for all animal species, including exotic animals. - Early Disease Detection: Facilitates early detection of diseases, contributing to improved patient outcomes and survival rates. - Cost Reduction: Reduces operational costs by an average of 35% by eliminating the need for external lab testing. - Increased Patient Capacity: Enhances clinic efficiency, allowing veterinarians to see and treat more patients by streamlining the diagnostic process. Primary Value and Problem Solved: Moichor addresses the need for faster, more accurate, and affordable diagnostic services in veterinary medicine. By integrating AI technology with in-clinic diagnostic capabilities, Moichor empowers veterinarians to make timely and informed decisions, leading to better patient care and outcomes. The Pathview system not only improves diagnostic accuracy but also enhances clinic efficiency and profitability by reducing reliance on external laboratories and associated costs.